Celltrion’s monoclonal antibody treatment regdanvimab, approved by the European Commission for the treatment of COVID-19
• The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week (11/11/2021)
AJC to host BIMP-EAGA virtual symposium series
“New Business Opportunities and Creating Sustainable Socio-Economic Landscape in BIMP-EAGA” on Nov 18, Nov 25, Dec 2, and Dec 9.
